ALNY
NASDAQ HealthcareAlnylam Pharmaceuticals, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $317.23 |
|---|---|
| Volume | 1,222,770 |
| Market Cap | 42.07B |
| Beta | 0.380 |
| RSI (14-Day) | 34.3 |
| 200-Day MA | $391.99 |
| 50-Day MA | $348.52 |
| 52-Week High | $495.55 |
| 52-Week Low | $205.87 |
| P/E Ratio | 135.57 |
| Forward P/E | 21.82 |
| Price / Book | 53.21 |
🎯 Investment Strategy Scores
How ALNY scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
46/100
High dividend yield + low volatility
🚀 Moon Shot
26/100
High growth potential (high beta + oversold)
🔪 Falling Knife
79/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
41/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
89/100
Large-cap, institutional-quality stocks
Find ALNY in your text
Paste any text on the homepage — the tool will extract ALNY and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.